Carlsbad, CA, United States of America

Christopher David King

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: **Christopher David King: Innovator in Pharmaceutical Patents**

Introduction

Christopher David King, an accomplished inventor based in Carlsbad, California, has made significant strides in pharmaceutical innovations. He holds a total of five patents, contributing to advancements in the field of respiratory and allergic disease treatments.

Latest Patents

Among his noteworthy inventions are two DP2 antagonists, which have been patented for their utility in treating various diseases. The first patent describes a compound known as DPantagonist 2-(3-(2-((tert-butylthio)methyl)-4-(2,2-dimethyl-propionylamino)phenoxy)-4-methoxyphenyl)acetic acid. This patent details methods for preparing the DPantagonist and outlines pharmaceutical compositions that include it. Uses for this compound encompass treatment for respiratory diseases, allergic conditions, and inflammatory conditions, as well as other prostaglandin D-dependent or mediated diseases.

The second patent describes another DP2 antagonist, [2'-(3-benzyl-1-ethyl-ureidomethyl)-6-methoxy-4'-trifluoromethyl-biphenyl-3-yl]-acetic acid, along with its pharmaceutical applications. Just like the first, it includes methods of preparation and suitable compositions for mammalian administration, targeting the same spectrum of diseases.

Career Highlights

Christopher has garnered experience and honed his expertise while working with companies such as Panmira Pharmaceuticals, LLC, and Brickell Biotech, Inc. His tenure in these organizations has facilitated the development of groundbreaking therapies that address pressing health issues.

Collaborations

Throughout his career, Christopher has collaborated with numerous professionals, including notable coworkers Jason Edward Brittain and Brian Andrew Stearns. These partnerships have further enriched his inventiveness and contributed to the advancement of his projects.

Conclusion

Christopher David King exemplifies the spirit of innovation within the pharmaceutical industry. With five patents to his name, his dedicated work toward developing effective treatments for respiratory and allergic diseases continues to impact the medical community positively. His contributions signify important advancements in health care, catering to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…